CRP and inflammatory bowel disease: Various changes in lipid profile have been described in human patients with inflammatory bowel disease, in addition to alterations in C-reactive protein (CRP) concentration, and paraoxonase-1 (PON-1) activity, an antioxidant enzyme that may be responsible for some alterations in the lipoprotein profile.